HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2).

AuthorsHanna Harno, Timo Hirvonen, Mari A Kaunisto, Heikki Aalto, Hilla Levo, Elina Isotalo, Hannu Somer, Mikko Kallela, Aarno Palotie, Maija Wessman, Markus Färkkilä
JournalJournal of neurology (J Neurol) Vol. 251 Issue 2 Pg. 232-4 (Feb 2004) ISSN: 0340-5354 [Print] Germany
PMID14991363 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anticonvulsants
  • CACNA1A protein, human
  • Calcium Channels
  • Acetazolamide
Topics
  • Acetazolamide (therapeutic use)
  • Adult
  • Anticonvulsants (therapeutic use)
  • Calcium Channels (genetics)
  • Cerebellum (pathology, physiopathology)
  • Chromosomes, Human, Pair 19 (genetics)
  • Dizziness (drug therapy, genetics, physiopathology)
  • Humans
  • Male
  • Mutation (genetics)
  • Ocular Motility Disorders (drug therapy, genetics, physiopathology)
  • Pedigree
  • Spinocerebellar Degenerations (drug therapy, genetics, physiopathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: